Looking ahead to 2035, the cold packs market will experience consistent growth fueled by advancements in material science, ...

Shares of biotech giant Regeneron Pharmaceuticals (NASDAQ: REGN) have staged a notable rebound, with a single-day surge exceeding 5%, drawing market attention. This rally interrupts a nearly ...

Del Taco's quiet exit from Florida caps a costly experiment that erased hundreds of millions of dollars in value and ...

PEP's PBNA unit gains momentum through innovation and cost cuts, strengthening its path toward mid-teens margins by 2026.

India’s latest quarterly GDP figures—clocking in at a robust 7 per cent + range according to Government estimates — have once ...

Musk sees a future where AI reshapes work and productivity, predicting rapid deflation, talent scarcity and a world where ...

Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of KYMBEEtm (deflazacort) Tablets, indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age ...

December 1, 2025Biodexa Announces Enrolment of First European Patients into Pivotal Phase 3 Serenta Trial in FAPBiodexa ...

Shares of Regeneron Pharmaceuticals ( REGN 0.56%), a biotech giant, have been southbound over the past two years as the ...

LG Energy Solution is making some big moves, especially with its plant in Michigan. They’re putting in a lot of money to make ...

Pfizer offers value with a strong dividend, Metsera obesity expansion, PADCEV/Keytruda approval, and an oncology pipeline.

In new research, an international team of researchers used high-resolution 3D imaging techniques, including microCT scanning, ...